Crow, Lauren D.
82  Ergebnisse:
Personensuche X
?
1

UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS..:

Catto, James WF ; Hussain, Syed A ; Tran, Ben...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S53 , 2024
 
?
2

MARKER LESION STUDY OF ORAL ERDAFITINIB IN PATIENTS WITH IN..:

Daneshmand, Siamak ; Zaucha, Renata ; Vasdev, Nikhil...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S58 , 2024
 
?
 
?
5

Comparative tolerability and efficacy of daylight, conventi..:

Crow, Lauren D. ; Saylor, Drew ; Griffith-Bauer, Kelly...
Journal of the American Academy of Dermatology.  85 (2021)  4 - p. 967-969 , 2021
 
?
6

An expert panel consensus on opioid-prescribing guidelines ..:

McLawhorn, Justin M. ; Stephany, Matthew P. ; Bruhn, William E....
Journal of the American Academy of Dermatology.  82 (2020)  3 - p. 700-708 , 2020
 
?
7

The bottom line: A novel medical approach for the treatment..:

Crow, Lauren ; Perkins, Ifeoma ; Twigg, Amanda.
International Journal of Women's Dermatology.  5 (2019)  3 - p. 194 , 2019
 
?
12

Quantifying Estrogen and Progesterone Receptor Expression i..:

Szeszel, Monika K. ; Crisman, Cameron L. ; Crow, Lauren...
Journal of Histochemistry & Cytochemistry.  53 (2005)  6 - p. 753-762 , 2005
 
?
15

JAAD-D-20-00839R2 Comparative tolerability and efficacy of ..:

Lauren Crow (10344646) ; Sarah Arron (3529829)
https://figshare.com/articles/dataset/JAAD-D-20-00839R2_Comparative_tolerability_and_efficacy_of_daylight_conventional_and_combination_aminolevulinic-acid-photodynamic_therapy_for_treatment_of_actinic_keratosis/14262343.  , 2021
 
1-15